NCT00974805View on ClinicalTrials.gov

An Investigation of the Mechanism of Action of Seretide in Chronic Obstructive Pulmonary Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

Seretide 500 Accuhaler

Seretide 500 accuhaler one inhalation BD

Trial Locations (1)

SO16 6YD

Southampton General Hospital, Southampton

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

University of Southampton

OTHER